American biotech firm that uses gene-editing to treat ultra-rare genetic disorders. Launched in early 2026 by Jennifer Doudna, Nobel-prizewinning pioneer of CRISPR gene-editing.
I used to think that the brain was the most wonderful organ in my body. Then I realized who was telling me this.